Number of the records: 1
Simultaneous delivery of doxorubicin and protease inhibitor derivative to solid tumors via star-shaped polymer nanomedicines overcomes P-gp- and STAT3-mediated chemoresistance
SYS 0558142 LBL 01000a^^22220027750^450 005 20250306131429.4 014 $a 85131813821 $2 SCOPUS 014 $a 35584053 $2 PUBMED 014 $a 000811352100001 $2 WOS 017 $a 10.1021/acs.biomac.2c00256 $2 DOI 100 $a 20220614d m y slo 03 ba 101 $a eng 102 $a US 200 1-
$a Simultaneous delivery of doxorubicin and protease inhibitor derivative to solid tumors via star-shaped polymer nanomedicines overcomes P-gp- and STAT3-mediated chemoresistance 215 $a 14 s. 463 -1
$1 001 cav_un_epca*0255862 $1 011 $a 1525-7797 $e 1526-4602 $1 200 1 $a Biomacromolecules $v Roč. 23, č. 6 (2022), s. 2522-2535 $1 210 $c American Chemical Society 610 $a HPMA 610 $a RAFT 610 $a star-like 700 -1
$3 cav_un_auth*0217115 $a Kostka $b Libor $p UMCH-V $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $w Biomacromolecular and bioanalogous systems: Therapeutics $4 070 $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0290087 $a Sivák $b Ladislav $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0103195 $a Šubr $b Vladimír $p UMCH-V $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $w Biomacromolecular and bioanalogous systems: Therapeutics $4 070 $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0297160 $a Kovářová $b Jiřina $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0104774 $a Šírová $b Milada $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0104733 $a Říhová $b Blanka $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $T Mikrobiologický ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0241788 $a Sedláček $b Radislav $p UMG-J $i Oddělení transgenních modelů nemocí $j Laboratory of Transgenic Models of Diseases $k 18 $l 18 $w Laboratory of Transgenic Models of Diseases $4 070 $T Ústav molekulární genetiky AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0103021 $a Etrych $b Tomáš $p UMCH-V $i Biomakromolekulární a bioanalogické systémy $j Biomacromolecular and Bioanalogous Systems $k BIOMOL $l BIOMOL $w Biomacromolecular and bioanalogous systems: Therapeutics $4 070 $z K $T Ústav makromolekulární chemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0104580 $a Kovář $b Marek $p MBU-M $i 152 - Laboratoř nádorové imunologie $j 152 - Laboratory of Tumor Immunology $w Laboratory of Tumor Immunology $4 070 $z K $T Mikrobiologický ústav AV ČR, v. v. i. 856 $u https://pubs.acs.org/doi/10.1021/acs.biomac.2c00256 $9 RIV
Number of the records: 1